1143536-01-9

Basic information

• Product Name: (R)-tert-butyl 4-(1-(4-chlorophenyl)ethylcarbamoyl)-4-cyanopiperidine-1-carboxylate
• Synonyms: (R)-tert-butyl 4-(1-(4-chlorophenyl)ethylcarbamoyl)-4-cyanopiperidine-1-carboxylate
• CAS NO: 1143536-01-9
• Molecular Weight: 391.898
• Mol File: 1143536-01-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-tert-butyl 4-(1-(4-chlorophenyl)ethylcarbamoyl)-4-cyanopiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-butyl 4-(1-(4-chlorophenyl)ethylcarbamoyl)-4-cyanopiperidine-1-carboxylate(1143536-01-9)
• EPA Substance Registry System: (R)-tert-butyl 4-(1-(4-chlorophenyl)ethylcarbamoyl)-4-cyanopiperidine-1-carboxylate(1143536-01-9)

Safety Data

• Hazardous Substances Data: 1143536-01-9(Hazardous Substances Data)

Upstream product

• 495415-34-4 1-(tert-butoxycarbonyl)-4-cyanopiperidine-4-carboxylic acid 
• 27298-99-3 (R)-1-(4-chlorophenyl)ethylamine 

Downstream Products

• 1143534-50-2 (R)-N-(1-(4-chlorophenyl)ethyl)-4-cyanopiperidine-4-carboxamide 

Relevant articles and documents

PYRROLO [2,3-D] PYRIMIDIN DERIVATIVES AS PROTEIN KINASE B INHIBITORS

The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I)